Tech Tuesday: University of Florida Researcher Develops AI Tool for Early Knee Osteoarthritis Detection (WCJB TV20)
In this week’s Tech Tuesday, UF Innovate spotlights University of Florida research that created an AI-powered tool for the early detection and severity prediction of knee osteoarthritis (OA).
Genascence Phase 1b DONATELLO Trial Evaluating Potential First-in-Class Gene Therapy for Knee Osteoarthritis (OA) Meets Primary Endpoint Showing GNSC-001 Was Safe and Well Tolerated Across Multiple Dosing Arms
UF startup Genascence Corporation announced positive 12-month safety and biomarker results from the Phase 1b DONATELLO clinical trial evaluating GNSC-001, a potential first-in-class gene therapy blocking interleukin 1 (IL-1) for the treatment of knee osteoarthritis (OA).